Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlethora Solutions Holdings Plc Regulatory News (PLE)

  • There is currently no data for PLE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

RULE 2.10 UPDATE

4 Nov 2015 18:28

RNS Number : 6200E
Plethora Solutions Holdings PLC
04 November 2015
 

Plethora Solutions Holdings PLC

("Plethora" or the "Company")

4 November 2015

RULE 2.10 UPDATE

In accordance with 2.10 of the City Code on Takeovers and Mergers (the "Code), the Company confirms that as at the date of this announcement, it has 823,297,686 ordinary shares of £0.01 each in issue with ISIN GB00B06GL868. Plethora's ordinary shares are listed on the Alternative Investment Market of the London Stock Exchange ("AIM").

In addition, Plethora has a number of warrants, convertible loans and options/share awards outstanding (none of which have an associated ISIN number). Details of these securities are included below.

Mellon Bridge Loans: a convertible loan note due to be repaid on 31 March 2010. Upon redemption, the loan may be converted to 17,000,000 ordinary shares of 1p at an exercise price of 2p per share.

Galloway loan warrant instrument: a warrant granted to Galloway Limited to subscribe for ordinary shares of 1p representing up to 5% of the fully diluted ordinary share capital (post exercise) at a price of 1.25p per share. The warrant is due to expire on 31 March 2023 and can be exercised at any point up to this date at the discretion of Galloway. Based on the current fully diluted ordinary share capital, the warrant allows Galloway to subscribe for up to 54,118,431 shares.

CfE loan warrant instrument: a warrant granted to the Capital for Enterprise fund to subscribe for ordinary shares of 1p representing up to 3% of the fully diluted ordinary share capital (post exercise) at a price of 1p per share. The warrant is due to expire on 31 March 2023 and can be exercised at any point up to this date at the discretion of Capital for Enterprise. Based on the current fully diluted ordinary share capital, the warrant allows Capital for Enterprise to subscribe for up to 32,471,058 shares.

Fundraising Warrants: warrants attached to the capital fundraising undertaken in September 2014. Up to 101,148,981 ordinary shares of 1p may be subscribed at an exercise price of 15p.

LTIPs: share awards under the Company's Long Term Incentive Plan. A total of 54,200,000 ordinary shares of 1p each will be awarded at no subscription cost to employees based on various commercial milestones. Additionally the LTIPs will automatically vest on a change of control of Plethora.

Executive Share Option Scheme (ESOP): available to all employees and directors of the Company. A total of 132,460 ordinary shares of 1p each may be issued in relation to the scheme at a subscription price of 59p per share.

 

Romero Tayong

Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RTTLLFFTLRLSIIE
Date   Source Headline
15th Mar 20132:57 pmRNSHolding(s) in Company
25th Feb 201311:07 amRNSStrategic review of The Urology Company Limited
14th Feb 20137:00 amRNSFinancing Update
5th Feb 201312:24 pmRNSRelated Party Transaction
5th Feb 20138:19 amRNSFinancing Update
7th Nov 20124:58 pmRNSHolding(s) in Company
28th Sep 20127:00 amRNSHalf Yearly Report
29th Jun 201211:55 amRNSReport & Accounts
29th Jun 20127:00 amRNSTotal Voting Rights
26th Jun 20125:15 pmRNSHolding(s) in Company
15th Jun 20124:11 pmRNSIssue of Equity - Directors' Interest
14th Jun 201212:05 pmRNSSubscription of Shares
24th Apr 201212:00 pmRNSChange of Registered Office
29th Mar 20127:00 amRNSPreliminary Results
15th Mar 20127:00 amRNSPSD502 Regulatory Submission Update
23rd Jan 20127:01 amRNSTrading Statement
20th Jan 20127:00 amRNSProduct Launch
6th Jan 20127:00 amRNSDirectorate Change
19th Dec 20117:00 amRNSProduct Update
31st Oct 20116:04 pmRNSTotal Voting Rights
14th Oct 20111:23 pmRNSResult of General Meeting
30th Sep 20117:00 amRNSHalf Yearly Report
28th Sep 20117:00 amRNSProposed Financing & Reduction of Debt
28th Sep 20117:00 amRNSAmendment to PSD502 Agreements
25th Jul 20117:00 amRNSStriant® SR commercial update
20th Jul 201112:09 pmRNSTrading Update
6th Jul 20111:24 pmRNSResult of AGM
24th Jun 20112:36 pmRNSReport and Accounts
20th Jun 20117:00 amRNSRe Agreement
9th Jun 201110:00 amRNSResignation of Dr Steven Powell
4th May 20117:00 amRNSExpansion of UK Sales Force
3rd May 20113:48 pmRNSTotal Voting Rights
28th Apr 20114:02 pmRNSDirector/PDMR Shareholding
28th Apr 20112:00 pmRNSHolding(s) in Company
20th Apr 20114:05 pmRNSResult of EGM
15th Apr 20117:00 amRNSHyalofemme Product Update
1st Apr 20117:00 amRNSFinal Results
1st Apr 20117:00 amRNSPlacing
14th Mar 20117:00 amRNSRe Agreement
11th Mar 20112:52 pmRNSDirectorate Change
24th Feb 201112:02 pmRNSHolding(s) in Company
3rd Feb 20119:48 amRNSDirector/PDMR Shareholding
3rd Feb 20117:00 amRNSTrading Update
28th Jan 20113:47 pmRNSHolding(s) in Company
22nd Dec 20104:42 pmRNSHolding(s) in Company
20th Dec 201010:24 amRNSResult of Meeting
20th Dec 20107:00 amRNSExpansion of Product Portfolio
3rd Dec 20107:05 amRNSBusiness Update & Proposed Placing
3rd Dec 20107:00 amRNSProduct Update
17th Nov 20107:01 amRNSLaunch of 3 New Products

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.